Maximizing the Treatment Benefit of tDCS in Neurodegenerative Anomia.

Roncero, Carlos; Service, Erik; De Caro, Marco; Popov, Aleksandar; Thiel, Alexander; Probst, Stephan; Chertkow, Howard

Roncero, Carlos; Service, Erik; De Caro, Marco; Popov, Aleksandar; Thiel, Alexander; Probst, Stephan; Chertkow, Howard.

Afiliação

Roncero C; Rotman Research Institute, Baycrest Health Sciences, Toronto, ON, Canada.
Service E; Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC, Canada.
De Caro M; Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC, Canada.
Popov A; Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC, Canada.
Thiel A; Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC, Canada.
Probst S; Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC, Canada.
Chertkow H; Department of Nuclear Medicine, McGill University, Montreal, QC, Canada.

Front Neurosci ; 13: 1231, 2019.

Article em En | MEDLINE | ID: mdl-31824242

Palavras-chave

PPA; anomia; object naming; tDCS; training

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: Front Neurosci Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google